# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-110142
Filing Date
2025-11-13
Accepted
2025-11-13 17:26:50
Documents
85
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | QUARTERLY REPORT | ea0264964-10q_onconetix.htm iXBRL | 10-Q | 1643039
2 | CERTIFICATION | ea026496401ex31_onconetix.htm | EX-31 | 12408
3 | CERTIFICATION | ea026496401ex32_onconetix.htm | EX-32 | 4813
| Complete submission text file | 0001213900-25-110142.txt |  | 9252618

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | XBRL SCHEMA FILE | onco-20250930.xsd | EX-101.SCH | 91616
5 | XBRL CALCULATION FILE | onco-20250930_cal.xml | EX-101.CAL | 59944
6 | XBRL DEFINITION FILE | onco-20250930_def.xml | EX-101.DEF | 448368
7 | XBRL LABEL FILE | onco-20250930_lab.xml | EX-101.LAB | 784062
8 | XBRL PRESENTATION FILE | onco-20250930_pre.xml | EX-101.PRE | 462567
87 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0264964-10q_onconetix_htm.xml | XML | 1197772

Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41294 | Film No.: 251479902
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)